Table 1 Characteristics of included studies
First Author (year) | Design | Center | Location | Type of OCT | PDT | anti-VEGF | Sex(male/female) | Agea(year) | Follow- upa(mo) | |
|---|---|---|---|---|---|---|---|---|---|---|
No. eyes/patients | No. eyes/patients | PDT | anti-VEGF | |||||||
Mitamura(2010)22 | Retro | 1 | Japan | TD-OCT | 49/49 | 22/22 | 7/42 | 5/17 | 73.0/69.6 | 3/3 |
Rouvas (2011)7 | Retro | 2 | Greece | SD-OCT | 11/11 | 10/10 | 6/5 | 5/5 | 62.9/66.5 | 12/12 |
Koh (2012)21 | RCT | 7 | Hong Kong, Singapore, Korea, Taiwan, Thailand | TD-OCT | 21/21 | 21/21 | 15/6 | 15/6 | 62.2/69.3 | 6/6 |
Oishi (2013)19 | RCT | 5 | Japan | SD-OCT | 47/47 | 46/46 | 32/15 | 28/18 | 75.0/75.4 | 12/12 |
Inoue (2013)20 | Retro | 1 | Japan | SD-OCT | 44/44 | 33/33 | 30/14 | 19/14 | 71.0/73.2 | 24/24 |
Kang (2014)18 | Retro | 1 | Korea | TD-OCT | 19/19 | 23/23 | NA | NA | 66.2/68.0 | 24/24 |